Unibest
← Back to patent-cliff list

CAS 1108743-56-1

N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-nitrobenzamide

Codes: ENTR-012

Application context (from source-drug indications)

Solid tumourEntrectinibNon-small cell lung cancerEntrectinib

Source drugs (routes using this intermediate)

DrugTierExpiry
EntrectinibTier C — Watch / trade2030

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Taizhou GMP-like Site5-(3,5-difluorobenzyl)-1H-indazol-3-amine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Workstert-butyl 4-(4-methylpiperazin-1-yl)-2-nitrobenzoate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site5-(3,5-difluorobenzyl)-2-fluorobenzonitrile
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Sitetert-butyl 2-amino-4-(4-methylpiperazin-1-yl)benzoate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works4-(4-methylpiperazin-1-yl)-2-[(tetrahydropyran-4-yl)(2,2,2-trifluoroacetyl)amino]benzoic acid trifluoroacetate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site4-(4-methylpiperazin-1-yl)-2-(2,2,2-trifluoro-N-(tetrahydro-2H-pyran-4-yl)acetamido)benzoicacid
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.